NFKB1 and neoplasm: Previous pre-clinical trials proposed that DMF inhibits tumour growth and distant metastasis, and restores sensitivity of CTCL cells towards apoptosis by down-regulating elevated nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) [76].